You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer
Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Neoadjuvant Enfortumab Vedotin-ejfv in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer
New Genetic Risk Score May Aid in Predicting the Likelihood of Developing, Dying From Prostate Cancer
NCCN Guidelines for Kidney Cancer (Version 3.2022)
Treatment-Related Regret Among Men With Localized Prostate Cancer: Examining Potential Factors